JUP and Alzheimer disease: Panza et al. recently advocated for clinical trials testing antibiotic therapy in AD patients exposed to suspected pathogens [14], while Dominy et al. proposed that brain-penetrant gingipain inhibitors could be more effective in reducing Pg brain infection and slowing or preventing disease progression without contributing to selective pressures for antibiotic resistance [11].